Botanix Pharmaceuticals Balance Sheet Health
Financial Health criteria checks 5/6
Botanix Pharmaceuticals has a total shareholder equity of A$45.4M and total debt of A$0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are A$47.7M and A$2.3M respectively.
Key information
0%
Debt to equity ratio
AU$0
Debt
Interest coverage ratio | n/a |
Cash | AU$18.31m |
Equity | AU$45.39m |
Total liabilities | AU$2.29m |
Total assets | AU$47.68m |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: BOT's short term assets (A$21.8M) exceed its short term liabilities (A$2.3M).
Long Term Liabilities: BOT has no long term liabilities.
Debt to Equity History and Analysis
Debt Level: BOT is debt free.
Reducing Debt: BOT has not had any debt for past 5 years.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: BOT has less than a year of cash runway based on its current free cash flow.
Forecast Cash Runway: BOT has sufficient cash runway for 1.3 years if free cash flow continues to reduce at historical rates of 10.9% each year.